First Five Patients Successfully Treated with atHeart Medical's Novel reSept(TM) Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

The first occluder with a metal-free, bioresorbable frame for the treatment of patients with clinically significant, isolated ASDs BAAR, Switzerland and MOUNTAIN VIEW, Calif., July 14, 2021 -- (Healthcare Sales & Marketing Network) -- atHeart Medical, ... Devices, Interventional, Cardiology atHeart Medical, reSept ASD Occluder, atrial septal defect
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news